Sartorius Aktiengesellschaft (0NIQ.L)
EUR 178.4
(1.02%)
EUR 178.4
(1.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 541 Million EUR | -54.47% |
| 2022 | 1.18 Billion EUR | 24.57% |
| 2021 | 953.86 Million EUR | 80.8% |
| 2020 | 527.58 Million EUR | 44.5% |
| 2019 | 365.11 Million EUR | 22.62% |
| 2018 | 297.75 Million EUR | 33.45% |
| 2017 | 223.11 Million EUR | 4.46% |
| 2016 | 213.58 Million EUR | 1.51% |
| 2015 | 210.41 Million EUR | 63.81% |
| 2014 | 128.44 Million EUR | 12.32% |
| 2013 | 114.35 Million EUR | -5.35% |
| 2012 | 120.81 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 143.8 Million EUR | 113.04% |
| 2024 Q2 | 106.3 Million EUR | -26.08% |
| 2024 Q3 | 127 Million EUR | 19.47% |
| 2023 FY | 544.6 Million EUR | -54.17% |
| 2023 Q4 | 67.5 Million EUR | -54.7% |
| 2023 Q2 | 215.5 Million EUR | -7.11% |
| 2023 Q1 | 232 Million EUR | -30.56% |
| 2023 Q3 | 149 Million EUR | -30.86% |
| 2022 Q2 | 296.9 Million EUR | -1.75% |
| 2022 Q1 | 302.2 Million EUR | 21.06% |
| 2022 FY | 1.18 Billion EUR | 24.57% |
| 2022 Q3 | 316.8 Million EUR | 6.7% |
| 2022 Q4 | 334.1 Million EUR | 5.46% |
| 2021 Q2 | 242.9 Million EUR | 17.97% |
| 2021 Q4 | 249.62 Million EUR | -10.11% |
| 2021 FY | 953.86 Million EUR | 80.8% |
| 2021 Q1 | 205.9 Million EUR | 11.64% |
| 2021 Q3 | 277.7 Million EUR | 14.33% |
| 2020 Q1 | 102.9 Million EUR | -8.69% |
| 2020 Q2 | 97.3 Million EUR | -5.44% |
| 2020 Q3 | 140.3 Million EUR | 44.19% |
| 2020 Q4 | 184.42 Million EUR | 31.45% |
| 2020 FY | 527.58 Million EUR | 44.5% |
| 2019 Q3 | 82.9 Million EUR | -4.71% |
| 2019 Q1 | 84.6 Million EUR | 1.69% |
| 2019 FY | 365.11 Million EUR | 22.62% |
| 2019 Q4 | 112.69 Million EUR | 35.94% |
| 2019 Q2 | 87 Million EUR | 2.84% |
| 2018 Q2 | 67.6 Million EUR | 7.3% |
| 2018 FY | 297.75 Million EUR | 33.45% |
| 2018 Q4 | 83.19 Million EUR | 12.43% |
| 2018 Q1 | 63 Million EUR | -18.47% |
| 2018 Q3 | 74 Million EUR | 9.47% |
| 2017 FY | 223.11 Million EUR | 4.46% |
| 2017 Q1 | 63 Million EUR | -19.68% |
| 2017 Q2 | 54.6 Million EUR | -13.33% |
| 2017 Q3 | 48.8 Million EUR | -10.62% |
| 2017 Q4 | 77.27 Million EUR | 58.35% |
| 2016 Q2 | 59.9 Million EUR | 6.77% |
| 2016 FY | 213.58 Million EUR | 1.51% |
| 2016 Q4 | 78.43 Million EUR | 35.46% |
| 2016 Q3 | 57.9 Million EUR | -3.34% |
| 2016 Q1 | 56.1 Million EUR | -3.63% |
| 2015 Q3 | 54.8 Million EUR | 13.69% |
| 2015 FY | 210.41 Million EUR | 63.81% |
| 2015 Q2 | 48.2 Million EUR | 8.8% |
| 2015 Q1 | 44.3 Million EUR | 28.97% |
| 2015 Q4 | 58.21 Million EUR | 6.23% |
| 2014 Q2 | 32.79 Million EUR | 24.24% |
| 2014 Q1 | 26.4 Million EUR | 14.01% |
| 2014 Q3 | 32.1 Million EUR | -2.13% |
| 2014 Q4 | 34.35 Million EUR | 7.01% |
| 2014 FY | 128.44 Million EUR | 12.32% |
| 2013 Q2 | 31.4 Million EUR | 10.18% |
| 2013 Q1 | 28.5 Million EUR | -10.42% |
| 2013 Q3 | 27.2 Million EUR | -13.38% |
| 2013 Q4 | 23.15 Million EUR | -14.87% |
| 2013 FY | 114.35 Million EUR | -5.35% |
| 2012 FY | 120.81 Million EUR | 0.0% |
| 2012 Q4 | 31.81 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cegedim SA | 19.98 Million EUR | -2607.301% |
| Guerbet SA | 38.67 Million EUR | -1298.981% |
| Nexus AG | 24.76 Million EUR | -2084.446% |
| Bastide Le Confort Médical SA | 44.22 Million EUR | -1123.373% |
| Revenio Group Oyj | 26.34 Million EUR | -1953.676% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | -216.04% |
| LNA Santé SA | 62.98 Million EUR | -758.989% |
| Siemens Healthineers AG | 2.86 Billion EUR | 81.143% |
| Medios AG | 31.37 Million EUR | -1624.523% |
| Equasens Société anonyme | 55.2 Million EUR | -879.93% |
| Stratec SE | 22.88 Million EUR | -2263.684% |